InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 13.11
+0.71 (5.73%)
At close: Mar 27, 2026
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 26.41 billion as of March 27, 2026. Its market cap has increased by 41.86% in one year.
Market Cap
26.41B
Enterprise Value
20.33B
Revenue
2.64B
Ranking
n/a
PE Ratio
36.94
Stock Price
13.11
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 26.41B, an increase of 115.08%. That is a compound annual growth rate of 13.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 25.08B | 5.89% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 37.50B |
| Shanghai Henlius Biotech | 35.87B |
| Shanghai Junshi Biosciences | 34.43B |
| TransThera Sciences (Nanjing) | 27.77B |
| Duality Biotherapeutics | 24.99B |
| Genscript Biotech | 23.68B |
| PegBio | 23.58B |
| Ascentage Pharma Group International | 16.28B |